Prime Capital Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,499
| Closed | -$238K | – | 931 |
|
|
2024
Q1 | $238K | Buy |
3,499
+212
| +6% | +$14.5K | ﹤0.01% | 856 |
|
|
2023
Q4 | $206K | Buy |
+3,287
| New | +$206K | ﹤0.01% | 872 |
|
|
2021
Q2 | – | Sell |
-527
| Closed | -$64K | – | 409 |
|
|
2021
Q1 | $64K | Buy |
527
+256
| +94% | +$31.1K | ﹤0.01% | 316 |
|
|
2020
Q4 | $41K | Buy |
271
+45
| +20% | +$6.81K | ﹤0.01% | 340 |
|
|
2020
Q3 | $19K | Buy |
+226
| New | +$19K | ﹤0.01% | 377 |
|